Nottingahshire apc
Nottinghamshire Area Prescribing Committee
  • Home
  • About
  • Shared Care
  • Guidelines/Formularies
    • Antimicrobial guidelines
  • JFG
    • Request a new medicine
  • Publications
    • Bulletins
    • Minutes of Meetings
    • Annual Reports
    • Stakeholder Survey
    • Publication Scheme
    • Privacy Policy
    • Website Disclaimer
    • Declarations of Interest
  • Links
  • Patient Info
  • De-prescribing/STOMP
  • COVID19
    • End of Life / Palliative Care (COVID)
    • COVID Treatment & Prevention
    • Respiratory
    • Anticoagulation & Haematology
    • Shared Care & High Risk Medicines
    • Prescribing - Clinical
    • Prescribing - Process
  • Home
  • COVID19
  • Anticoagulation & Haematology

Anticoagulation & Haematology - COVID FAQs

To ensure that you are seeing the most up to date information, refresh the page by pressing Ctrl and F5 together.

  • Is the anticoagulation service able to manage the change of patients from warfarin to DOAC e.g. counselling? (111 kb)
  • Can we extend the INR testing interval? (117 kb)
  • Should I switch patients from Vitamin B12 injections onto oral treatment or delay injections? (230 kb)
  • Can the DOAC monitoring interval be extended? (491 kb)
  • Should I switch warfarin to a DOAC? (276 kb)
  • Vitamin-D and COVID-19: does deficiency risk a poorer outcome? (489 kb)

Nottinghamshire Joint Formulary


© 2021 Nottinghamshire APC | Website Accessibility Statement